CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs.
Saved in:
| Title: | CGRP monoclonal antibodies in migraine: an efficacy and tolerability comparison with standard prophylactic drugs. |
|---|---|
| Authors: | Vandervorst F; Department of Neurology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., Van Deun L; Department of Neurology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium., Van Dycke A; Department of Neurology, General Hospital Sint-Jan Bruges, Bruges, Belgium., Paemeleire K; Department of Neurology, Ghent University Hospital, Ghent, Belgium., Reuter U; Department of Neurology, Charité Universitätsmedizin Berlin, Berlin, Germany., Schoenen J; Headache Research Unit, Dept of Neurology-Citadelle Hospital, University of Liège, Liège, Belgium., Versijpt J; Department of Neurology, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium. jan.versijpt@uzbrussel.be. |
| Source: | The journal of headache and pain [J Headache Pain] 2021 Oct 25; Vol. 22 (1), pp. 128. Date of Electronic Publication: 2021 Oct 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100940562 Publication Model: Electronic Cited Medium: Internet ISSN: 1129-2377 (Electronic) Linking ISSN: 11292369 NLM ISO Abbreviation: J Headache Pain Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
